Contraindicated. Coadministration not proposed; powerful cytochrome P450 enzyme inducers reduce systemic publicity to roflumilast and could lessen the therapeutic usefulnessKeep track of Closely (one)phenobarbital will decrease the extent or outcome of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Lack